Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaccines | 14 | 2023 | 823 | 2.670 |
Why?
|
Vaccination | 23 | 2023 | 3275 | 2.530 |
Why?
|
Immunization Programs | 10 | 2021 | 260 | 2.320 |
Why?
|
Pneumococcal Vaccines | 5 | 2020 | 391 | 2.070 |
Why?
|
Pneumococcal Infections | 5 | 2020 | 497 | 1.940 |
Why?
|
Economics | 8 | 2014 | 146 | 1.440 |
Why?
|
Cost of Illness | 7 | 2023 | 1859 | 1.190 |
Why?
|
Public Health | 11 | 2021 | 2603 | 1.160 |
Why?
|
Commerce | 6 | 2019 | 592 | 1.120 |
Why?
|
Health Policy | 16 | 2022 | 2662 | 1.100 |
Why?
|
Population Dynamics | 8 | 2014 | 302 | 1.100 |
Why?
|
Cost-Benefit Analysis | 23 | 2023 | 5388 | 1.070 |
Why?
|
Models, Economic | 4 | 2019 | 712 | 1.070 |
Why?
|
Meningococcal Infections | 3 | 2020 | 77 | 1.070 |
Why?
|
India | 25 | 2024 | 2200 | 1.040 |
Why?
|
Streptococcus pneumoniae | 3 | 2020 | 714 | 1.020 |
Why?
|
Meningococcal Vaccines | 2 | 2020 | 95 | 0.880 |
Why?
|
Developed Countries | 9 | 2019 | 437 | 0.880 |
Why?
|
Gross Domestic Product | 6 | 2023 | 77 | 0.870 |
Why?
|
Visually Impaired Persons | 1 | 2022 | 79 | 0.810 |
Why?
|
Economic Development | 5 | 2020 | 69 | 0.780 |
Why?
|
Delivery of Health Care | 10 | 2021 | 5319 | 0.770 |
Why?
|
Poverty Areas | 5 | 2015 | 275 | 0.760 |
Why?
|
Public-Private Sector Partnerships | 2 | 2021 | 121 | 0.750 |
Why?
|
Vision, Low | 1 | 2022 | 166 | 0.740 |
Why?
|
Developing Countries | 14 | 2023 | 2815 | 0.740 |
Why?
|
Socioeconomic Factors | 13 | 2023 | 7784 | 0.740 |
Why?
|
Income | 5 | 2023 | 1913 | 0.710 |
Why?
|
Carbamates | 1 | 2021 | 196 | 0.710 |
Why?
|
Health Status | 6 | 2023 | 4031 | 0.700 |
Why?
|
Drug Resistance, Microbial | 3 | 2020 | 860 | 0.700 |
Why?
|
Acquired Immunodeficiency Syndrome | 10 | 2016 | 2232 | 0.680 |
Why?
|
Women's Health | 3 | 2020 | 2033 | 0.660 |
Why?
|
Life Expectancy | 7 | 2014 | 1184 | 0.660 |
Why?
|
Hypothermia | 2 | 2017 | 189 | 0.650 |
Why?
|
Infant Equipment | 1 | 2017 | 24 | 0.620 |
Why?
|
Technology Assessment, Biomedical | 1 | 2020 | 306 | 0.620 |
Why?
|
Achievement | 2 | 2018 | 290 | 0.610 |
Why?
|
Water Supply | 2 | 2015 | 214 | 0.570 |
Why?
|
Population Density | 3 | 2014 | 196 | 0.570 |
Why?
|
Infant Care | 1 | 2017 | 179 | 0.550 |
Why?
|
Dengue | 2 | 2017 | 256 | 0.550 |
Why?
|
Health Services Needs and Demand | 5 | 2021 | 1411 | 0.550 |
Why?
|
Health Services for the Aged | 2 | 2014 | 269 | 0.510 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 156 | 0.510 |
Why?
|
Population Growth | 3 | 2011 | 52 | 0.490 |
Why?
|
Private Sector | 1 | 2017 | 393 | 0.490 |
Why?
|
Social Behavior | 1 | 2021 | 1126 | 0.480 |
Why?
|
Hepatitis C | 2 | 2022 | 1591 | 0.480 |
Why?
|
Humans | 135 | 2024 | 743811 | 0.470 |
Why?
|
Accidents, Traffic | 1 | 2019 | 819 | 0.460 |
Why?
|
Mass Vaccination | 2 | 2014 | 105 | 0.450 |
Why?
|
Longitudinal Studies | 13 | 2023 | 13980 | 0.430 |
Why?
|
Mortality | 5 | 2021 | 2862 | 0.420 |
Why?
|
Communicable Diseases | 3 | 2019 | 880 | 0.410 |
Why?
|
Health Care Rationing | 1 | 2015 | 437 | 0.400 |
Why?
|
World Health Organization | 7 | 2019 | 1317 | 0.400 |
Why?
|
Needs Assessment | 5 | 2013 | 1146 | 0.390 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2022 | 1537 | 0.390 |
Why?
|
Dementia | 5 | 2023 | 2518 | 0.380 |
Why?
|
Health Expenditures | 4 | 2021 | 2348 | 0.380 |
Why?
|
Demography | 8 | 2013 | 1653 | 0.380 |
Why?
|
Communicable Disease Control | 5 | 2024 | 856 | 0.370 |
Why?
|
Neisseria meningitidis, Serogroup B | 2 | 2020 | 6 | 0.370 |
Why?
|
United Nations | 3 | 2021 | 165 | 0.360 |
Why?
|
Child Mortality | 2 | 2016 | 198 | 0.350 |
Why?
|
Antiviral Agents | 2 | 2022 | 2984 | 0.350 |
Why?
|
Anti-HIV Agents | 7 | 2016 | 4255 | 0.350 |
Why?
|
Infant Mortality | 2 | 2013 | 755 | 0.340 |
Why?
|
Aortic Valve Stenosis | 1 | 2022 | 1955 | 0.340 |
Why?
|
Interinstitutional Relations | 2 | 2000 | 240 | 0.340 |
Why?
|
Convalescence | 1 | 2009 | 105 | 0.340 |
Why?
|
Aging | 10 | 2023 | 8655 | 0.340 |
Why?
|
Vaccines, Conjugate | 2 | 2020 | 333 | 0.320 |
Why?
|
Mental Disorders | 2 | 2023 | 6593 | 0.320 |
Why?
|
Research | 9 | 2023 | 1999 | 0.310 |
Why?
|
Physician Incentive Plans | 1 | 2009 | 161 | 0.310 |
Why?
|
HIV Infections | 15 | 2016 | 16715 | 0.300 |
Why?
|
Antiretroviral Therapy, Highly Active | 5 | 2016 | 1872 | 0.300 |
Why?
|
China | 4 | 2023 | 2243 | 0.300 |
Why?
|
Immunization Schedule | 2 | 2019 | 221 | 0.300 |
Why?
|
Social Class | 4 | 2015 | 1997 | 0.290 |
Why?
|
Medically Underserved Area | 1 | 2009 | 252 | 0.290 |
Why?
|
Drug Discovery | 1 | 2015 | 1058 | 0.290 |
Why?
|
Rheumatic Heart Disease | 2 | 2020 | 177 | 0.280 |
Why?
|
Mental Health | 4 | 2024 | 3012 | 0.280 |
Why?
|
Haemophilus influenzae type b | 2 | 2019 | 16 | 0.270 |
Why?
|
Bacterial Vaccines | 2 | 2018 | 403 | 0.270 |
Why?
|
Haemophilus Vaccines | 2 | 2019 | 69 | 0.270 |
Why?
|
Fertility | 6 | 2016 | 779 | 0.260 |
Why?
|
Rural Health Services | 1 | 2009 | 380 | 0.260 |
Why?
|
Air Pollution | 1 | 2019 | 2286 | 0.260 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3155 | 0.260 |
Why?
|
Conservation of Natural Resources | 1 | 2007 | 204 | 0.260 |
Why?
|
Biomedical Research | 1 | 2021 | 3308 | 0.260 |
Why?
|
Prevalence | 11 | 2023 | 15211 | 0.260 |
Why?
|
Influenza Vaccines | 2 | 2022 | 738 | 0.250 |
Why?
|
Efficiency | 3 | 2020 | 462 | 0.230 |
Why?
|
Planets | 1 | 2023 | 7 | 0.230 |
Why?
|
Ontario | 2 | 2018 | 383 | 0.230 |
Why?
|
Health Care Costs | 6 | 2022 | 3207 | 0.220 |
Why?
|
Evaluation Studies as Topic | 2 | 1998 | 1677 | 0.220 |
Why?
|
Models, Theoretical | 10 | 2017 | 3587 | 0.220 |
Why?
|
Marriage | 5 | 1990 | 339 | 0.220 |
Why?
|
Virology | 1 | 2023 | 76 | 0.220 |
Why?
|
Aged | 23 | 2024 | 163178 | 0.220 |
Why?
|
Attitude to Health | 3 | 2009 | 2052 | 0.220 |
Why?
|
Human Rights | 2 | 2021 | 307 | 0.210 |
Why?
|
Employment | 4 | 1995 | 1132 | 0.210 |
Why?
|
Pharyngitis | 1 | 2023 | 215 | 0.200 |
Why?
|
Urinary Bladder Diseases | 1 | 2022 | 166 | 0.200 |
Why?
|
Salaries and Fringe Benefits | 3 | 1995 | 263 | 0.200 |
Why?
|
Age Factors | 11 | 2021 | 18355 | 0.200 |
Why?
|
Urination Disorders | 1 | 2022 | 241 | 0.200 |
Why?
|
Health Status Disparities | 2 | 2015 | 1796 | 0.190 |
Why?
|
Brazil | 2 | 2023 | 1264 | 0.190 |
Why?
|
Urbanization | 1 | 2021 | 104 | 0.190 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5752 | 0.180 |
Why?
|
Least-Squares Analysis | 1 | 2021 | 379 | 0.180 |
Why?
|
Child | 19 | 2023 | 77637 | 0.180 |
Why?
|
Pandemics | 8 | 2024 | 8385 | 0.180 |
Why?
|
Fellowships and Scholarships | 1 | 2008 | 1077 | 0.180 |
Why?
|
Retinoscopy | 1 | 2019 | 27 | 0.180 |
Why?
|
Substance Abuse, Intravenous | 1 | 2005 | 525 | 0.180 |
Why?
|
Female | 45 | 2023 | 380020 | 0.180 |
Why?
|
Family Characteristics | 5 | 2015 | 1000 | 0.180 |
Why?
|
Neisseria meningitidis, Serogroup A | 1 | 2019 | 6 | 0.180 |
Why?
|
Organizations | 2 | 2017 | 170 | 0.180 |
Why?
|
International Normalized Ratio | 1 | 2021 | 367 | 0.170 |
Why?
|
Emigration and Immigration | 2 | 2008 | 402 | 0.170 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2022 | 435 | 0.170 |
Why?
|
Ebola Vaccines | 1 | 2019 | 24 | 0.170 |
Why?
|
Turkey | 1 | 2020 | 237 | 0.170 |
Why?
|
Streptococcal Infections | 1 | 2023 | 636 | 0.170 |
Why?
|
Hospitalization | 2 | 2020 | 10259 | 0.170 |
Why?
|
Measles Vaccine | 1 | 2019 | 76 | 0.170 |
Why?
|
Veterans Health | 1 | 2021 | 216 | 0.170 |
Why?
|
Adaptation, Psychological | 2 | 2009 | 2575 | 0.170 |
Why?
|
France | 1 | 2020 | 517 | 0.170 |
Why?
|
Refraction, Ocular | 1 | 2019 | 181 | 0.160 |
Why?
|
Blindness | 1 | 2022 | 612 | 0.160 |
Why?
|
Virus Diseases | 2 | 2023 | 711 | 0.160 |
Why?
|
Residence Characteristics | 4 | 2015 | 2050 | 0.160 |
Why?
|
Bacterial Capsules | 1 | 2019 | 251 | 0.160 |
Why?
|
Germany | 1 | 2020 | 862 | 0.160 |
Why?
|
Refractive Errors | 1 | 2019 | 141 | 0.160 |
Why?
|
Geography | 2 | 2014 | 669 | 0.160 |
Why?
|
United States | 20 | 2022 | 69859 | 0.150 |
Why?
|
Male | 36 | 2023 | 349776 | 0.150 |
Why?
|
Forecasting | 3 | 2018 | 2950 | 0.150 |
Why?
|
South Africa | 6 | 2016 | 1731 | 0.150 |
Why?
|
Anthropometry | 2 | 2019 | 1348 | 0.150 |
Why?
|
Ecology | 1 | 1998 | 105 | 0.150 |
Why?
|
Government | 2 | 2019 | 165 | 0.150 |
Why?
|
Cardiovascular Diseases | 3 | 2019 | 15142 | 0.150 |
Why?
|
Investments | 2 | 2016 | 143 | 0.150 |
Why?
|
Seasons | 2 | 2021 | 1493 | 0.150 |
Why?
|
Climate | 1 | 1998 | 147 | 0.150 |
Why?
|
Systems Biology | 1 | 2020 | 470 | 0.140 |
Why?
|
Nepal | 1 | 2017 | 295 | 0.140 |
Why?
|
Data Collection | 2 | 2014 | 3339 | 0.140 |
Why?
|
Quality Improvement | 4 | 2021 | 3750 | 0.140 |
Why?
|
Drugs, Generic | 1 | 2021 | 421 | 0.140 |
Why?
|
Health Care Sector | 1 | 2018 | 194 | 0.140 |
Why?
|
Prejudice | 3 | 2000 | 569 | 0.140 |
Why?
|
Quality of Life | 4 | 2021 | 12788 | 0.140 |
Why?
|
Denmark | 1 | 2018 | 738 | 0.140 |
Why?
|
Middle Aged | 22 | 2024 | 213241 | 0.140 |
Why?
|
Infertility, Female | 1 | 2022 | 788 | 0.130 |
Why?
|
Computers | 1 | 1998 | 602 | 0.130 |
Why?
|
Family Planning Services | 2 | 2016 | 263 | 0.130 |
Why?
|
Sex Ratio | 2 | 2015 | 109 | 0.130 |
Why?
|
Policy Making | 4 | 2023 | 554 | 0.130 |
Why?
|
Nutritional Requirements | 1 | 2017 | 286 | 0.130 |
Why?
|
Health Personnel | 1 | 2008 | 3217 | 0.130 |
Why?
|
Travel | 1 | 2021 | 788 | 0.130 |
Why?
|
Adult | 23 | 2023 | 213889 | 0.130 |
Why?
|
Prescription Drugs | 1 | 2022 | 593 | 0.130 |
Why?
|
Disease Outbreaks | 2 | 2007 | 1771 | 0.120 |
Why?
|
Interviews as Topic | 2 | 2020 | 2538 | 0.120 |
Why?
|
Child, Preschool | 11 | 2021 | 40964 | 0.120 |
Why?
|
Temperature | 1 | 2021 | 2202 | 0.120 |
Why?
|
Gonorrhea | 1 | 2018 | 335 | 0.120 |
Why?
|
Acculturation | 1 | 1995 | 182 | 0.120 |
Why?
|
Antihypertensive Agents | 2 | 2022 | 2047 | 0.120 |
Why?
|
Anti-Retroviral Agents | 2 | 2016 | 1714 | 0.120 |
Why?
|
Drug Approval | 1 | 2020 | 742 | 0.120 |
Why?
|
Blood Pressure | 3 | 2022 | 8551 | 0.120 |
Why?
|
Disability Evaluation | 1 | 2021 | 1828 | 0.120 |
Why?
|
Portugal | 1 | 2013 | 86 | 0.120 |
Why?
|
Dengue Vaccines | 1 | 2013 | 14 | 0.120 |
Why?
|
Hepatitis C, Chronic | 1 | 2022 | 1029 | 0.110 |
Why?
|
Neuropsychological Tests | 3 | 2023 | 6976 | 0.110 |
Why?
|
Poverty | 4 | 2022 | 2660 | 0.110 |
Why?
|
Cognition | 3 | 2020 | 6759 | 0.110 |
Why?
|
Disabled Persons | 2 | 2021 | 1214 | 0.110 |
Why?
|
Adolescent | 19 | 2023 | 85729 | 0.110 |
Why?
|
Maternal Age | 4 | 1986 | 802 | 0.110 |
Why?
|
Americas | 5 | 1995 | 110 | 0.110 |
Why?
|
National Health Programs | 2 | 2014 | 445 | 0.110 |
Why?
|
Health Status Indicators | 1 | 2018 | 970 | 0.110 |
Why?
|
Research Design | 3 | 2020 | 5983 | 0.110 |
Why?
|
Birth Rate | 3 | 2011 | 170 | 0.110 |
Why?
|
International Cooperation | 3 | 2014 | 1419 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1372 | 0.110 |
Why?
|
Vesico-Ureteral Reflux | 1 | 1996 | 427 | 0.110 |
Why?
|
Water Microbiology | 1 | 2013 | 117 | 0.110 |
Why?
|
Health Behavior | 2 | 2017 | 2634 | 0.100 |
Why?
|
Quality Control | 1 | 2015 | 841 | 0.100 |
Why?
|
Nutrition Policy | 1 | 2016 | 488 | 0.100 |
Why?
|
Aortic Valve | 1 | 2022 | 1920 | 0.100 |
Why?
|
Program Evaluation | 2 | 2012 | 2483 | 0.100 |
Why?
|
Models, Econometric | 2 | 2010 | 218 | 0.100 |
Why?
|
Biological Assay | 1 | 2015 | 650 | 0.100 |
Why?
|
Climate Change | 1 | 2017 | 418 | 0.100 |
Why?
|
Circumcision, Male | 1 | 2012 | 150 | 0.100 |
Why?
|
Infant | 9 | 2021 | 35122 | 0.100 |
Why?
|
Liver Cirrhosis | 1 | 2021 | 1859 | 0.100 |
Why?
|
Aged, 80 and over | 6 | 2023 | 57744 | 0.100 |
Why?
|
Public Policy | 1 | 1995 | 572 | 0.100 |
Why?
|
Cohort Studies | 8 | 2024 | 40545 | 0.100 |
Why?
|
Statistics as Topic | 6 | 1993 | 2369 | 0.100 |
Why?
|
Haemophilus Infections | 1 | 2010 | 95 | 0.090 |
Why?
|
Influenza, Human | 1 | 2022 | 1480 | 0.090 |
Why?
|
Long-Term Care | 1 | 2014 | 606 | 0.090 |
Why?
|
Visual Acuity | 1 | 2019 | 2525 | 0.090 |
Why?
|
Infant, Newborn | 8 | 2021 | 25609 | 0.090 |
Why?
|
Drug Resistance, Bacterial | 1 | 2017 | 1030 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2022 | 3921 | 0.090 |
Why?
|
Africa South of the Sahara | 2 | 2012 | 724 | 0.090 |
Why?
|
Nursing Methodology Research | 1 | 2009 | 67 | 0.090 |
Why?
|
Financing, Organized | 1 | 2011 | 202 | 0.090 |
Why?
|
Quebec | 1 | 2009 | 134 | 0.090 |
Why?
|
Adolescent Behavior | 1 | 1998 | 1151 | 0.090 |
Why?
|
North America | 5 | 1995 | 1249 | 0.090 |
Why?
|
Battered Women | 1 | 2009 | 36 | 0.090 |
Why?
|
Qualitative Research | 3 | 2021 | 2682 | 0.090 |
Why?
|
Students | 1 | 2019 | 1647 | 0.090 |
Why?
|
HIV | 2 | 2016 | 1604 | 0.080 |
Why?
|
Age Distribution | 2 | 2012 | 2899 | 0.080 |
Why?
|
Host-Pathogen Interactions | 1 | 2017 | 1479 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3047 | 0.080 |
Why?
|
Fiji | 2 | 2020 | 47 | 0.080 |
Why?
|
Risk Factors | 10 | 2022 | 72252 | 0.080 |
Why?
|
Young Adult | 6 | 2023 | 56392 | 0.080 |
Why?
|
Midwestern United States | 1 | 2008 | 70 | 0.080 |
Why?
|
Birth Order | 2 | 1993 | 95 | 0.080 |
Why?
|
Sex Factors | 4 | 2015 | 10394 | 0.080 |
Why?
|
Southeastern United States | 1 | 2008 | 95 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2022 | 3338 | 0.080 |
Why?
|
Spouse Abuse | 1 | 2009 | 178 | 0.080 |
Why?
|
Immunity, Herd | 2 | 2020 | 44 | 0.080 |
Why?
|
Population Characteristics | 4 | 1995 | 11 | 0.080 |
Why?
|
Nurse's Role | 1 | 2009 | 209 | 0.070 |
Why?
|
Educational Status | 4 | 2023 | 2540 | 0.070 |
Why?
|
Rural Population | 1 | 2017 | 2207 | 0.070 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7172 | 0.070 |
Why?
|
Population | 4 | 1995 | 141 | 0.070 |
Why?
|
Immunization | 1 | 2011 | 1255 | 0.070 |
Why?
|
Quality-Adjusted Life Years | 2 | 2013 | 1683 | 0.070 |
Why?
|
Unemployment | 1 | 1988 | 214 | 0.070 |
Why?
|
C-Reactive Protein | 2 | 2015 | 3778 | 0.070 |
Why?
|
Morbidity | 2 | 2023 | 1768 | 0.070 |
Why?
|
Comorbidity | 1 | 2021 | 10380 | 0.070 |
Why?
|
Urban Population | 1 | 2014 | 2021 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3020 | 0.070 |
Why?
|
Papillomavirus Vaccines | 1 | 2012 | 491 | 0.070 |
Why?
|
Vietnam | 2 | 2019 | 408 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2278 | 0.070 |
Why?
|
Diet | 2 | 2017 | 7930 | 0.070 |
Why?
|
HIV Seropositivity | 1 | 1991 | 971 | 0.070 |
Why?
|
Patient Preference | 1 | 2012 | 889 | 0.060 |
Why?
|
Needle-Exchange Programs | 1 | 2005 | 25 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 7729 | 0.060 |
Why?
|
Self Care | 1 | 2009 | 786 | 0.060 |
Why?
|
Hypertension | 2 | 2022 | 8480 | 0.060 |
Why?
|
Monte Carlo Method | 1 | 2008 | 1254 | 0.060 |
Why?
|
Drug Industry | 2 | 2018 | 746 | 0.060 |
Why?
|
Models, Biological | 3 | 2012 | 9582 | 0.060 |
Why?
|
Drug Monitoring | 1 | 2009 | 953 | 0.060 |
Why?
|
Body Height | 2 | 2019 | 1579 | 0.050 |
Why?
|
Energy Intake | 1 | 2010 | 2149 | 0.050 |
Why?
|
Body Mass Index | 2 | 2019 | 12718 | 0.050 |
Why?
|
Georgia | 1 | 2022 | 187 | 0.050 |
Why?
|
Health Services Accessibility | 2 | 2010 | 5136 | 0.050 |
Why?
|
Pregnancy | 5 | 2021 | 29140 | 0.050 |
Why?
|
Africa | 2 | 2007 | 672 | 0.050 |
Why?
|
Mammography | 1 | 2012 | 2475 | 0.050 |
Why?
|
Chronic Disease | 2 | 2017 | 9139 | 0.050 |
Why?
|
Streptococcus pyogenes | 1 | 2023 | 289 | 0.050 |
Why?
|
Belgium | 1 | 2020 | 103 | 0.050 |
Why?
|
Marital Status | 2 | 2009 | 437 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2012 | 1587 | 0.050 |
Why?
|
Costs and Cost Analysis | 3 | 2012 | 1680 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2022 | 63042 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2012 | 2018 | 0.040 |
Why?
|
Meningitis, Haemophilus | 1 | 2019 | 21 | 0.040 |
Why?
|
Financial Support | 1 | 2000 | 115 | 0.040 |
Why?
|
Social Support | 1 | 2009 | 2118 | 0.040 |
Why?
|
Caregivers | 2 | 2021 | 2098 | 0.040 |
Why?
|
Australia | 1 | 2022 | 1167 | 0.040 |
Why?
|
Goals | 2 | 2016 | 708 | 0.040 |
Why?
|
Computer Simulation | 2 | 2012 | 6188 | 0.040 |
Why?
|
Internationality | 1 | 2005 | 1002 | 0.040 |
Why?
|
Viruses | 1 | 2023 | 374 | 0.040 |
Why?
|
Drug Utilization | 2 | 2007 | 1183 | 0.040 |
Why?
|
Early Detection of Cancer | 1 | 2012 | 3089 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2000 | 438 | 0.040 |
Why?
|
International Agencies | 1 | 2019 | 240 | 0.040 |
Why?
|
Social Sciences | 1 | 1998 | 45 | 0.040 |
Why?
|
Urologic Surgical Procedures | 1 | 2000 | 301 | 0.040 |
Why?
|
Malaria Vaccines | 1 | 2018 | 158 | 0.040 |
Why?
|
Patient Care Team | 1 | 2008 | 2528 | 0.040 |
Why?
|
Focus Groups | 2 | 2014 | 1320 | 0.040 |
Why?
|
Health Priorities | 1 | 2000 | 380 | 0.040 |
Why?
|
Ethiopia | 1 | 2019 | 495 | 0.040 |
Why?
|
Gene Transfer, Horizontal | 1 | 2017 | 144 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4210 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 2 | 2013 | 2560 | 0.040 |
Why?
|
Mass Screening | 1 | 2012 | 5251 | 0.040 |
Why?
|
Program Development | 2 | 2014 | 1314 | 0.040 |
Why?
|
Internal-External Control | 1 | 1978 | 363 | 0.040 |
Why?
|
Delphi Technique | 1 | 2019 | 777 | 0.030 |
Why?
|
Neisseria gonorrhoeae | 1 | 2018 | 238 | 0.030 |
Why?
|
Illegitimacy | 1 | 1995 | 4 | 0.030 |
Why?
|
Social Problems | 1 | 1995 | 112 | 0.030 |
Why?
|
Cost Sharing | 1 | 2018 | 407 | 0.030 |
Why?
|
Social Change | 1 | 1995 | 153 | 0.030 |
Why?
|
Indonesia | 1 | 2015 | 119 | 0.030 |
Why?
|
Health | 1 | 1998 | 394 | 0.030 |
Why?
|
Information Dissemination | 1 | 2023 | 1099 | 0.030 |
Why?
|
Filtration | 1 | 2014 | 233 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 21675 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2017 | 723 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 1999 | 546 | 0.030 |
Why?
|
Zambia | 1 | 2013 | 261 | 0.030 |
Why?
|
Transients and Migrants | 1 | 1995 | 155 | 0.030 |
Why?
|
Motivation | 1 | 2022 | 1971 | 0.030 |
Why?
|
Incidence | 3 | 2012 | 20948 | 0.030 |
Why?
|
Drug Costs | 1 | 2000 | 1105 | 0.030 |
Why?
|
Plasmids | 1 | 2017 | 2308 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2017 | 999 | 0.030 |
Why?
|
Propensity Score | 1 | 2019 | 1781 | 0.030 |
Why?
|
History, 20th Century | 1 | 2000 | 2736 | 0.030 |
Why?
|
Parents | 2 | 2022 | 3403 | 0.030 |
Why?
|
Prospective Studies | 3 | 2021 | 53250 | 0.030 |
Why?
|
Violence | 1 | 1998 | 909 | 0.030 |
Why?
|
Sarcopenia | 1 | 2017 | 368 | 0.030 |
Why?
|
Geographic Information Systems | 1 | 2014 | 281 | 0.030 |
Why?
|
Environment | 1 | 1998 | 1121 | 0.020 |
Why?
|
Stress, Psychological | 2 | 2014 | 4245 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 9944 | 0.020 |
Why?
|
Health Planning | 1 | 2012 | 237 | 0.020 |
Why?
|
Self Report | 1 | 2022 | 3550 | 0.020 |
Why?
|
Schools | 1 | 2019 | 1432 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2015 | 1364 | 0.020 |
Why?
|
Urban Health | 1 | 2013 | 547 | 0.020 |
Why?
|
Civil Rights | 1 | 1991 | 132 | 0.020 |
Why?
|
Canada | 1 | 1995 | 2064 | 0.020 |
Why?
|
Eligibility Determination | 1 | 2013 | 404 | 0.020 |
Why?
|
Education | 1 | 1993 | 543 | 0.020 |
Why?
|
Federal Government | 1 | 1991 | 260 | 0.020 |
Why?
|
Jordan | 1 | 2009 | 74 | 0.020 |
Why?
|
Hemoglobins | 1 | 2015 | 1531 | 0.020 |
Why?
|
Health Promotion | 2 | 2014 | 2205 | 0.020 |
Why?
|
Animals | 2 | 2019 | 168660 | 0.020 |
Why?
|
Survival Analysis | 2 | 2015 | 10251 | 0.020 |
Why?
|
Industry | 1 | 1991 | 366 | 0.020 |
Why?
|
Community Health Services | 1 | 2014 | 650 | 0.020 |
Why?
|
Body Weight | 1 | 1979 | 4670 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2018 | 1956 | 0.020 |
Why?
|
Sexual Behavior | 1 | 1998 | 2049 | 0.020 |
Why?
|
Blood Glucose | 1 | 2022 | 6259 | 0.020 |
Why?
|
Decision Making | 2 | 2016 | 3887 | 0.020 |
Why?
|
Mathematics | 2 | 1979 | 727 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3748 | 0.020 |
Why?
|
Health Education | 1 | 2014 | 1056 | 0.020 |
Why?
|
Reproductive History | 2 | 1993 | 209 | 0.020 |
Why?
|
Disease | 1 | 1992 | 680 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5714 | 0.020 |
Why?
|
Weight Gain | 1 | 2016 | 2294 | 0.020 |
Why?
|
Angiomatosis | 1 | 1966 | 49 | 0.020 |
Why?
|
Indoles | 1 | 1974 | 1841 | 0.020 |
Why?
|
Photosensitivity Disorders | 1 | 1966 | 77 | 0.020 |
Why?
|
Personnel Selection | 1 | 2007 | 190 | 0.020 |
Why?
|
Population Surveillance | 2 | 2009 | 2614 | 0.020 |
Why?
|
Sincalide | 1 | 1985 | 16 | 0.020 |
Why?
|
Career Mobility | 1 | 2007 | 262 | 0.020 |
Why?
|
Life Style | 1 | 2017 | 3833 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 20827 | 0.020 |
Why?
|
Dwarfism | 1 | 1966 | 145 | 0.020 |
Why?
|
Survival Rate | 1 | 1999 | 12786 | 0.020 |
Why?
|
Child Welfare | 1 | 2008 | 523 | 0.020 |
Why?
|
Anxiety | 2 | 2014 | 4288 | 0.010 |
Why?
|
Infection Control | 1 | 2011 | 964 | 0.010 |
Why?
|
Neurosecretory Systems | 1 | 1985 | 231 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2009 | 934 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3608 | 0.010 |
Why?
|
Refugees | 1 | 2009 | 511 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7908 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 1998 | 4254 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25032 | 0.010 |
Why?
|
Parity | 1 | 1984 | 929 | 0.010 |
Why?
|
Finland | 1 | 1982 | 602 | 0.010 |
Why?
|
Italy | 1 | 1982 | 829 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5952 | 0.010 |
Why?
|
Family Relations | 1 | 1982 | 321 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1998 | 19894 | 0.010 |
Why?
|
Boston | 1 | 2012 | 9310 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 1993 | 12243 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2014 | 4370 | 0.010 |
Why?
|
Leukemia | 1 | 1966 | 1509 | 0.010 |
Why?
|
Verbal Behavior | 1 | 1978 | 340 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29052 | 0.010 |
Why?
|
Time Factors | 3 | 1984 | 40038 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2017 | 8035 | 0.010 |
Why?
|
Europe | 1 | 1982 | 3336 | 0.010 |
Why?
|
Insurance, Health | 1 | 1988 | 2492 | 0.010 |
Why?
|
Depression | 1 | 2014 | 7760 | 0.010 |
Why?
|
Social Welfare | 1 | 1995 | 87 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35409 | 0.010 |
Why?
|
Perception | 1 | 1978 | 1198 | 0.010 |
Why?
|
Proteinuria | 1 | 1974 | 658 | 0.010 |
Why?
|
Financial Management | 1 | 1993 | 160 | 0.010 |
Why?
|
Probability | 1 | 1995 | 2505 | 0.010 |
Why?
|
Benzamides | 1 | 1974 | 1383 | 0.010 |
Why?
|
Retrospective Studies | 1 | 1996 | 77410 | 0.000 |
Why?
|
Piperidines | 1 | 1974 | 1601 | 0.000 |
Why?
|
Schizophrenia | 1 | 1985 | 6865 | 0.000 |
Why?
|
Receptors, Dopamine | 1 | 1985 | 295 | 0.000 |
Why?
|
Jews | 1 | 1966 | 385 | 0.000 |
Why?
|
Heart Rate | 1 | 1974 | 4091 | 0.000 |
Why?
|
Chromosome Disorders | 1 | 1966 | 510 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 1995 | 12354 | 0.000 |
Why?
|
Chromosome Aberrations | 1 | 1966 | 1811 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1985 | 6030 | 0.000 |
Why?
|
Antipsychotic Agents | 1 | 1985 | 3057 | 0.000 |
Why?
|